News and Events

Softigel® by Procaps to feature UnigelTM technology during Cphi Japan

UnigelTM technology during Cphi Japan

Softigel® by Procaps, a leading provider of contract development and manufacturing services in softgel technologies, will feature its novel technology for fixed dose combinations, UnigelTM, during Cphi Japan.

UnigelTM  is a first-to-market technology designed to combine multiple api formulations in one single soft gelatin capsule, offering multi-phase therapies, improving bioavailability, reducing manufacturing costs, and achieving superior adherence to different therapies. UnigelTM technology provides various forms for fixed-dose combinations, such as a softgel in a softgel, a tablet in a softgel, granules in a softgel, or any combination to address challenges of multiactive formulation, offering unique prescription, otc and otx products.

About Softigel® by Procaps

Softigel® by Procaps is a leading provider of Contract Development and Manufacturing services in softgel advanced technologies for the global pharmaceutical and nutraceutical industry. Through our extensive capabilities and deep expertise in product development and softgel manufacturing, we help different companies bring innovative products to their markets faster, offering their patients and consumers an exceptional experience, high preference and superior adherence to different therapies.  Our advanced delivery technologies, including Softgel and related technologies, our proven formulation, manufacturing and regulatory expertise, has enabled us to become an integrated CDMO (iCDMO), giving customers full-service, turnkey solutions in prescription drugs, OTC and dietary supplements across both development and delivery.  

Meet with Softigel® during CPhI Japan

Softigel team of experts will be available to discuss the company’s new offerings at Booth 2F-28.

Schedule a meeting with us here